Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07413133
PHASE1

A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.

Official title: A Phase 1 Pharmacokinetic Study in Healthy Adult Volunteers to Evaluate the Bioavailability of ABBV-8736 Following Subcutaneous Administration Relative to Intravenous Administration

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-02-11

Completion Date

2026-06

Last Updated

2026-03-04

Healthy Volunteers

Yes

Interventions

DRUG

ABBV-8736

Intravenous Injection

DRUG

ABBV-8736

Subcutaneous Injection

Locations (2)

CenExel ACT- Anaheim Clinical Trials /ID# 280481

Anaheim, California, United States

Acpru /Id# 280382

Grayslake, Illinois, United States